Comparative Study of Anaconda System Use Versus Conventional Sedation in COVID-19 Patients.

H

Hospital Español de Mexico

Status

Completed

Conditions

COVID-19
Respiratory Failure

Treatments

Device: Sevoflurane with AnaConDa

Study type

Observational

Funder types

Other

Identifiers

NCT06208592
2020-01-Anaconda

Details and patient eligibility

About

At the beginning of 2020, a global alert emerged which saturated intensive care units due to COVID-19 worldwide. This caused a need for mechanical ventilation due to atypical pneumonias that had a rapid evolution and respiratory failure; therefore the consumption of sedative agents in the intensive care units escalated. Suboptimal sedation in the intensive care unit, increases the adverse effects, costs, and morbidity. For the time being, they focus on the use of intravenous agents such as propofol or dexmedetomidine, which are associated with tolerance, withdrawal, delirium, and hemodynamic effects. Consequently, the need arises to maximize availability and effectiveness, which is why the intervention of the ANACONDA conservation device is carried out, which works with a heat and humidity exchange filter capable of administering isoflurane or sevoflurane with an efficiency of 90%.

Full description

Analyze the difference in intravenous sedation requirements in patients with COVID-19. Patients who were assisted by a mechanical ventilator with sevoflurane versus conventional sedation.

Enrollment

43 patients

Sex

All

Ages

27 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patients with confirmed COVI-19 infection and assited with mechanical ventilation who entered critical care department.

Exclusion criteria

  • Tranfers to a different hospital.
  • Death within the first 24 hours of hospital stay.

Trial design

43 participants in 2 patient groups

Anaconda Group
Description:
Use of Anaconda devide at any point during the initial follow up (7 days) additional of conventional intravenous sedation
Treatment:
Device: Sevoflurane with AnaConDa
Non-Anaconda Group
Description:
Use on conventional intravenous sedation, not using Anaconda device

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems